Charles River Laboratories | CRL - Selling And Administration Expenses

Stock Price
211.82
Daily Change
1.34 0.64%
Monthly
1.68%
Yearly
31.06%
Q1 Forecast
204.00

Charles River Laboratories reported $177.59M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Align Technology USD 417.8M 30.89M Sep/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Bruker USD 242.5M 11.1M Sep/2025
Cardinal Health USD 1.46B 23M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cigna USD 3.19B 242M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Dentsply International USD 355M 21M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Humana USD 3.36B 614M Mar/2025
Illumina USD 256M 59M Sep/2025
Incyte USD 329.08M 1.94M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
McKesson USD 2.07B 122M Sep/2025
Merck EUR 1.46B 16M Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Quest Diagnostics USD 501M 15M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
United Therapeutics USD 152M 60.5M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Waters USD 214.23M 12.97M Sep/2025
West Pharmaceutical Services USD 102.7M 6.8M Sep/2025